Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Etoricoxib Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4465565
  • 140 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Etoricoxib in recent years and the growth of consumers' demand is expected to drive the global Etoricoxib market.

Geographically, the global Etoricoxib market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Etoricoxib market in North America.

Significant participants active in the global Etoricoxib market include: Abbott, Pfizer, Sun Pharmaceutical, GlaxoSmithKline, Bayer, Perrigo, Kopran, Merck, Geri-Care, Novacap...

Global Etoricoxib Market Segmentation:

Etoricoxib market, by Etoricoxib type:

n-House Manufacturing

Contract Manufacturing Organizations

…

Etoricoxib market, by Application:

Rheumatoid Arthritis

Psoriatic Arthritis

Osteoarthritis

Ankylosing Spondylitis

Chronic Low Back Pain

Acute Pain

Others

…

Etoricoxib Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Etoricoxib by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Etoricoxib Market-Segmentation

4.1 By Type

4.1.1 n-House Manufacturing

4.1.2 Contract Manufacturing Organizations

4.2 By End-User/Application Industry

4.2.1 Rheumatoid Arthritis

4.2.2 Psoriatic Arthritis

4.2.3 Osteoarthritis

4.2.4 Ankylosing Spondylitis

4.2.5 Chronic Low Back Pain

4.2.6 Acute Pain

4.2.7 Others

4.3 By Geography

4.3.1 North America Etoricoxib Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Etoricoxib Production from 2014-2020

4.3.1.2 North America Etoricoxib Consumption from 2014-2020

4.3.1.3 North America Etoricoxib Import and Export from 2014-2020

4.3.1.4 North America Etoricoxib Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Etoricoxib Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Etoricoxib Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Etoricoxib Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Etoricoxib Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Etoricoxib Production from 2014-2020

4.3.2.2 Europe Etoricoxib Consumption from 2014-2020

4.3.2.3 Europe Etoricoxib Import and Export from 2014-2020

4.3.2.4 Europe Etoricoxib Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Etoricoxib Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Etoricoxib Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Etoricoxib Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Etoricoxib Production from 2014-2020

4.3.3.2 Asia-Pacific Etoricoxib Consumption from 2014-2020

4.3.3.3 Asia-Pacific Etoricoxib Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Etoricoxib Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Etoricoxib Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Etoricoxib Production from 2014-2020

4.3.4.2 Latin America Etoricoxib Consumption from 2014-2020

4.3.4.3 Latin America Etoricoxib Import and Export from 2014-2020

4.3.4.4 Latin America Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Etoricoxib Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Etoricoxib Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Etoricoxib Production from 2014-2020

4.3.5.2 Middle East & Africa Etoricoxib Consumption from 2014-2020

4.3.5.3 Middle East & Africa Etoricoxib Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Etoricoxib Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Abbott

5.1.1 Abbott Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Abbott Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Pfizer

5.2.1 Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Sun Pharmaceutical

5.3.1 Sun Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Sun Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2020

5.4 GlaxoSmithKline

5.4.1 GlaxoSmithKline Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Bayer

5.5.1 Bayer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Bayer Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Perrigo

5.6.1 Perrigo Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Perrigo Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Kopran

5.7.1 Kopran Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Kopran Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Merck

5.8.1 Merck Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Merck Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Geri-Care

5.9.1 Geri-Care Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Geri-Care Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Novacap

5.10.1 Novacap Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Novacap Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Etoricoxib Market from 2021-2026

7.1 Future Forecast of Global Etoricoxib Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Etoricoxib Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Etoricoxib Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Etoricoxib Market Value ($) and Growth Rate of Etoricoxib from 2014-2026

Global Etoricoxib Production and Growth Rate Segment by Product Types from 2014-2026F

Global Etoricoxib Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Etoricoxib Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Etoricoxib Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure n-House Manufacturing of Etoricoxib

Figure Contract Manufacturing Organizations of Etoricoxib

Table Global Etoricoxib Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Etoricoxib Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Rheumatoid Arthritis of Etoricoxib

Figure Psoriatic Arthritis of Etoricoxib

Figure Osteoarthritis of Etoricoxib

Figure Ankylosing Spondylitis of Etoricoxib

Figure Chronic Low Back Pain of Etoricoxib

Figure Acute Pain of Etoricoxib

Figure Others of Etoricoxib

Table Global Etoricoxib Production Value ($) by Regions

Table Global Etoricoxib Production Value Share by Regions

Table Global Etoricoxib Production by Regions

Table Global Etoricoxib Production Share by Regions

Table Global Etoricoxib Consumption by Regions

Table Global Etoricoxib Consumption Share by Regions

Figure North America Etoricoxib Production and Growth Rate from 2014-2020

Figure North America Etoricoxib Consumption and Growth Rate from 2014-2020

Table North America Etoricoxib Import and Export from 2014-2020

Table North America Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

Table North America Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

Table North America Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Etoricoxib Participants Value ($) and Market Share (%) in 2019

Figure Europe Etoricoxib Production and Growth Rate from 2014-2020

Figure Europe Etoricoxib Consumption and Growth Rate from 2014-2020

Table Europe Etoricoxib Import and Export from 2014-2020

Table Europe Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

Table Europe Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

Table Europe Etoricoxib Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Etoricoxib Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Etoricoxib Production and Growth Rate from 2014-2020

Figure Asia-Pacific Etoricoxib Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Etoricoxib Import and Export from 2014-2020

Table Asia-Pacific Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Etoricoxib Participants Value ($) and Market Share (%) in 2019

Figure Latin America Etoricoxib Production and Growth Rate from 2014-2020

Figure Latin America Etoricoxib Consumption and Growth Rate from 2014-2020

Table Latin America Etoricoxib Import and Export from 2014-2020

Table Latin America Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Etoricoxib Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Etoricoxib Production and Growth Rate from 2014-2020

Figure Middle East & Africa Etoricoxib Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Etoricoxib Import and Export from 2014-2020

Table Middle East & Africa Etoricoxib Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Etoricoxib Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Etoricoxib Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Etoricoxib Participants Value ($) and Market Share (%) in 2019

Table Abbott Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Abbott Sales and Growth Rate from 2014-2020

Figure Abbott Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Sales and Growth Rate from 2014-2020

Figure Pfizer Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sun Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sun Pharmaceutical Sales and Growth Rate from 2014-2020

Figure Sun Pharmaceutical Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GlaxoSmithKline Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GlaxoSmithKline Sales and Growth Rate from 2014-2020

Figure GlaxoSmithKline Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Bayer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Bayer Sales and Growth Rate from 2014-2020

Figure Bayer Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Perrigo Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Perrigo Sales and Growth Rate from 2014-2020

Figure Perrigo Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Kopran Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Kopran Sales and Growth Rate from 2014-2020

Figure Kopran Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Merck Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Merck Sales and Growth Rate from 2014-2020

Figure Merck Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Geri-Care Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Geri-Care Sales and Growth Rate from 2014-2020

Figure Geri-Care Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Novacap Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Novacap Sales and Growth Rate from 2014-2020

Figure Novacap Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Etoricoxib Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Etoricoxib Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Etoricoxib Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Etoricoxib Production and Growth Rate Forecast by Types (2021-2026)

Table Global Etoricoxib Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390